Design and Biological Evaluation of Manganese‐ and Ruthenium‐Based Hybrid CO‐RMs (HYCOs)-Reference-Cited by-同舟云学术

Design and Biological Evaluation of Manganese‐ and Ruthenium‐Based Hybrid CO‐RMs (HYCOs)

Published:2019-08-23 Issue:18 Volume:14 Page:1684-1691
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Ollivier Anthony¹,Foresti Roberta²³^ORCID,El Ali Zeina²³,Martens Thierry¹^ORCID,Kitagishi Hiroaki⁴^ORCID,Motterlini Roberto²³^ORCID,Rivard Michael¹^ORCID

Affiliation:

1. Université Paris Est, ICMPE (UMR 7182)CNRS, UPEC 94320 Thiais France

2. INSERM U955 Equipe 12 94000 Créteil France

3. Université Paris EstFaculté de Médecine 94000 Créteil France

4. Department of Molecular Chemistry and BiochemistryFaculty of Science and EngineeringDoshisha University Kyotanabe, Kyoto 610-0321 Japan

Funder

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.201900426

Reference63 articles.

2. Use of carbon monoxide as a therapeutic agent: promises and challenges

3. The therapeutic potential of carbon monoxide

5. CORM‐A1: a new pharmacologically active carbon monoxide‐releasing molecule

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An orally active carbon monoxide-releasing molecule enhances beneficial gut microbial species to combat obesity in mice;Redox Biology;2024-06

2. A Review on the Recent Advancements on Therapeutic Effects of Ions in the Physiological Environments;Prosthesis;2022-06-20

3. New Coordination Compounds Based on a Pyrazine Derivative: Design, Characterization, and Biological Study;Molecules;2022-05-27

4. CO and Pain Management;Carbon Monoxide in Drug Discovery;2022-05-07

5. Metal‐Based Carbon Monoxide‐Releasing Molecules (CO‐RMs) as Pharmacologically Active Therapeutics;Carbon Monoxide in Drug Discovery;2022-05-07